Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial
Cell Therapy Transplant Canada
科研成果: 期刊稿件 › 文章 › 同行评审
70
引用
（Scopus）